Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
12.16
+0.23 (1.93%)
Oct 9, 2026, 3:12 PM EDT - Market open
Biohaven Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Biohaven stock has a consensus rating of "Buy" and an average price target of $21.27. The average 1-year stock price forecast is 74.92% higher than the current stock price, while the lowest is $10 (-17.76%) and the highest is $42 (+245.39%).
Price Target: $21.27 (+74.92%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Biohaven stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 9 | 9 | 9 | 9 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 5 | 4 | 3 | 3 | 4 | 4 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $21 | Buy | Reiterates | $21 | +72.70% | Oct 9, 2026 |
| Citi | Citi | Buy Maintains $17 | Buy | Maintains | $17 | +39.80% | Sep 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $10 | Hold | Maintains | $10 | -17.76% | Sep 10, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 10, 2026 |
Financial Forecast
Revenue This Year
50.00M
Revenue Next Year
39.99M
from 50.00M
Decreased by -20.02%
EPS This Year
-1.65
from -5.55
EPS Next Year
-1.87
from -1.65
EPS and Forward PE are based on non-GAAP adjusted numbers.